Arrowstreet Capital, Limited Partnership Regeneron Pharmaceuticals, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

$122 Billion
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $1.58 Million - $1.88 Million	2,262 New	2,262 $1.63 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $463,063 - $502,751	656 Added 65.27%	1,661 $1.2 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $102 Million - $129 Million	-177,537 Reduced 99.44%	1,005 $692,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $78 Million - $105 Million	142,319 Added 392.9%	178,542 $106 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $18.8 Million - $22.1 Million	31,609 Added 685.07%	36,223 $25.3 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $2.51 Million - $3.1 Million	4,614 New	4,614 $2.91 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $312,711 - $383,740	-700 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $5.5 Million - $6.99 Million	-11,500 Reduced 94.26%	700 $338,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $6.65 Million - $8.03 Million	12,200 New	12,200 $6.83 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $110 Million - $128 Million	-403,526 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $27.9 Million - $38.7 Million	93,195 Added 30.03%	403,526 $126 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $86.8 Million - $103 Million	233,356 Added 303.16%	310,331 $127 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $25.8 Million - $31 Million	76,975 New	76,975 $28.8 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $315,820 - $393,780	-1,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $358,630 - $469,950	1,000	1,000 $376,000

Others Institutions Holding REGN

# of Institutions

1,493

Shares Held

85.8M

Call Options Held

1.53M

Put Options Held

1.44M

Vanguard Group Inc Valley Forge, PA

9.29M
Shares

$6.49 Billion
0.12% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$5.9 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

7.06M
Shares

$4.93 Billion
0.41% of portfolio
State Street Corp Boston, MA

4.83M
Shares

$3.38 Billion
0.14% of portfolio
Capital International Investors Los Angeles, CA

4.74M
Shares

$3.31 Billion
0.66% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account